NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / Technology News / Recovered COVID-19 patients need only one shot of mRNA vaccines
    Next Article
    Recovered COVID-19 patients need only one shot of mRNA vaccines

    Recovered COVID-19 patients need only one shot of mRNA vaccines

    By Nikita Gupta
    (PTI desk)
    Feb 04, 2021
    05:04 pm

    What's the story

    People who have recovered from COVID-19 may need only one shot as opposed to the recommended two jabs if they are taking the Moderna or Pfizer vaccines, according to a study that suggests ways to minimize doses when supplies are limited.

    The yet-to-be peer-reviewed study, posted in the preprint repository medRxiv, assessed the antibody responses in 109 individuals with and without documented pre-existing immunity.

    COVID-19 research

    Recovered individuals have a rapid immune response to one dose

    According to the researchers, including Florian Krammer from the Icahn School of Medicine, a single dose of mRNA vaccine elicits very rapid immune responses in individuals already possessing antibodies against the coronavirus from previous exposure to it.

    "For individuals with pre-existing immunity to SARS-CoV-2, the first vaccine dose immunologically resembles the booster dose in naive individuals," the scientists wrote in the study.

    Information

    How do mRNA vaccines work in fighting the virus?

    In the research, the scientists analyzed mRNA vaccines that use segments of the viral genetic material to enable human cells to make the coronavirus spike proteins. These proteins train the immune system of vaccine recipients to fight the actual infectious coronavirus when encountering the pathogen.

    Further details

    Post-vaccine antibody levels in recovered patients much higher than others

    The post-vaccine antibody levels in recovered COVID-19 patients are comparable to or exceed levels found in those without prior exposure to the virus who received two doses.

    Another yet-to-be peer-reviewed study in medRxiv found that antibody levels in recovered healthcare workers started peaking at seven days since immunization, and achieved higher titers and neutralization in 14 days compared to first-time vaccine receivers.

    Quote

    Peak titers developed after one jab of vaccine

    "Although we did not have peak titers for these individuals after natural infection, the titers developed after single vaccination was higher than peak titers in COVID-19 patients, similar to what was described in primary vaccination after two doses of the spike-based mRNA vaccines," researchers said.

    COVID-19 vaccination

    Recovered people can be placed lower in vaccination priority list

    According to the scientists from the University of Maryland School of Medicine, the secondary response occurs through activation of the immune system's memory B cells.

    Based on the findings, the researchers recommend a strategy of single-dose vaccination for patients who have already had laboratory-confirmed COVID-19. They said those who have recovered from the disease can be placed lower on the vaccination priority list.

    Difference of opinions

    It may be safer that everyone gets two doses: Riley

    Commenting on the two studies, Eleanor Riley, Professor of Immunology and Infectious Disease at the University of Edinburgh said the vaccines are effectively boosting immunity induced by infection.

    However, while the two studies suggest only one dose for those recovered, Riley said incorporating this into a mass vaccination program may be logistically complex. It may be safer to ensure that everyone gets two doses.

    Research and findings

    Reports should not be relied on to guide clinical practice

    The preprint platform, medRxiv, also cautions that the posted reports are preliminary in nature and have not been certified by peer review. "They should not be relied on to guide clinical practice or health-related behavior," it adds.

    Lawrence Young, Virologist and Professor of Molecular Oncology, the University of Warwick in the UK, believes this question can be resolved with further studies.

    Information

    This can be a viable option to solve vaccine crisis

    "If future work can confirm this high level of immunity post a single mRNA vaccine in the group of previously infected individuals, this could become a viable option when there are concerns around vaccine supply," Young said.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Pfizer
    Coronavirus
    Moderna Inc

    Latest

    Notable records of Novak Djokovic at French Open French Open
    Virat Kohli averages 51-plus in winning cause (Tests): Stats Virat Kohli
    India Women squad named for England tour; Shafali Verma returns BCCI
    These South African players will miss IPL 2025 playoffs Indian Premier League (IPL)

    Pfizer

    Coronavirus vaccine in 2020? US drugmaker Pfizer isn't saying no! Donald Trump
    Pfizer, BioNTech say their COVID-19 vaccine is over 90% effective Vaccine
    Trump says Pfizer withheld announcement on COVID-19 vaccine before election Donald Trump
    Meet the husband-wife duo behind Pfizer-BioNTech's COVID-19 vaccine Reuters

    Coronavirus

    Sri Lanka to procure two to three million Covishield doses India
    COVAXIN may neutralize UK strain of COVID-19: Review report Bharat Biotech
    Coronavirus: India's tally reaches 10.7 million with 11K+ new cases India
    Improve health system to tackle COVID-19 crisis in future: Gopinath International Monetary Fund

    Moderna Inc

    Moderna's COVID-19 vaccine gets FDA nod for phase 2 trial Oxford University
    Moderna's COVID-19 vaccine shows 'positive' results in human trials United States of America
    Why the vaccine for COVID-19 is still several months away Coronavirus
    Moderna's COVID-19 vaccine: When will it be available? COVID-19
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025